| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Chief Commerical Officer
2 companies
Baldry Mark is a Chief Commerical Officer at WVE with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 3 sells.
Estimated insider holdings value: $390K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | XFOR X4 Pharmaceuticals, Inc | Chief Commercial Officer | Buy | 1,032 | $2.48 | $2,561.42 | +4.2% | +7.5% | - | |
| Jan 24, 2025 | XFOR X4 Pharmaceuticals, Inc | Chief Commercial Officer | Sell | 29,159 | $0.45 | $13,241.10 | -23.7% | -60.8% | -74.2% | |
| Nov 15, 2024 | XFOR X4 Pharmaceuticals, Inc | Chief Commercial Officer | Buy | 35,050 | $0.55 | $19,251.91 | +16.7% | +24.6% | -69.8% | |
| Oct 7, 2024 | XFOR X4 Pharmaceuticals, Inc | Chief Commercial Officer | Sell | 11,127 | $0.58 | $6,505.96 | -18.7% | +40.0% | -78.3% | |
| Nov 1, 2023 | XFOR X4 Pharmaceuticals, Inc | Chief Commercial Officer | Sell | 10,257 | $0.73 | $7,487.61 | -29.4% | +6.8% | -33.4% |